Navigation Links
ULURU Inc. Reports Second Quarter 2013 Financial Results
Date:8/15/2013

ADDISON, Texas, Aug. 15, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the second quarter ended June 30, 2013 and provided a review of its operating activities.

During the second quarter continued progress was made towards the expansion of commercialization of Altrazeal® in international markets:

  • Orders were received from 4 new markets, and production was initiated for the following;
  • Czech Republic, Slovakia, Portugal and South Africa;
  • Advanced discussions on the expansion of strategic relationships for major territories; and
  • Initiated a controlled clinical study to demonstrate the cost effectiveness of Altrazeal®.
  • Commenting on the business activities, Kerry P. Gray, President and CEO, stated, "Our previous guidance for revenue growth and positive cash flow in the fourth quarter remains unchanged. Our international partnership activities have now been expanded to include Latin America and Asia. These activities will further accelerate our global growth. We remain focused on achieving our commercialization objectives for the upcoming 18 months of marketing Altrazeal® in 50 markets and we believe we are on track to achieve this objective. Activities have also commenced to further enhance the clinical package supporting Altrazeal® by undertaking additional controlled studies to demonstrate clinical benefit and cost advantage."  

    For the second quarter of 2013, the Company reported a net loss of $0.8 million, or $0.06 per share, compared with a net loss of $0.9 million, or $0.11 per share, for the same period last year.  For the six months ended June 30, 2013, the reported net loss was $1.5 million, or $0.12 per share, compared with a net loss of $1.7 million, or $0.21 per share, for the same period last year.

    Commenting on the financial results Kerry P. Gray, President
    '/>"/>

    SOURCE ULURU Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
    2. ULURU Inc. Reports First Quarter 2013 Financial Results
    3. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
    4. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
    5. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
    6. ULURU Inc. Business Update And Outlook
    7. ULURU Inc. Announces Closing Of $440,000 Private Placement
    8. ULURU Inc. Reports Third Quarter 2012 Financial Results
    9. ULURU Inc. Announces The First Shipment Of Veterinary Product
    10. ULURU Inc. Announces First Order Of Altrazeal For European Launch
    11. ULURU Inc. Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
    (Date:8/29/2014)... Research and Markets  has announced the addition of ... 2014-2018" report to their offering. ... connect, support, or surround bones. There are several types ... fascia, and other fibrous tissues. Repetitive use, accidents, injuries, ... in wear and tear in these tissues. Orthopedic soft ...
    (Date:8/28/2014)... 28, 2014  Rigrodsky & Long, P.A.: , ... (NYSE: LCI )? , Did you purchase your ... July 16, 2014, inclusive? , Did you lose money ... you want to discuss your rights? ... Attorney, Timothy J. MacFall , announces that a complaint has ...
    Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
    (Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has ... four reports are titled:, , Revealing the Truth ... , The Top 5 Things You Should Know Before ... in Children , Dr. Mary Anne Larkin choose to ... confusion and misinformation about each them. The reports are available ...
    (Date:8/29/2014)... La Mirada, CA (PRWEB) August 29, 2014 ... multidisciplinary healthcare organizations, acquired a new medical center from LAXMed. ... LAX airport and less than 2 miles west of the ... Healthpointe center within Southern California. The new LAX center is ... CA 90045. , The new Healthpointe LAX ...
    (Date:8/29/2014)... August 29, 2014 The family of ... a series of dialysis treatments has filed a GranuFlo ... was the result of Fresenius Medical Care’s GranuFlo and ... lawsuit, which was file d in Alameda County Superior ... of the products resulted in metabolic alkalosis, a ...
    (Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... “The Safety Chick” who profiled a handful of ... Earphones from Etymotic Research. This year, many schools ... and Etymotic, an innovator of hearing wellness solutions, ... Their ETY•Kids Safe-Listening Earphones, offered in yellow, pink ...
    (Date:8/29/2014)... Steven Reinberg ... News) -- The vast majority of American babies are ... serious illnesses, federal health officials said Thursday. More ... that prevent measles, mumps, and rubella (MMR); polio; hepatitis ... for Disease Control and Prevention. "Nationally, vaccination among ...
    Breaking Medicine News(10 mins):Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
    ... Meeting of the European Society of Cardiology Council on ... with the Irish Nurses Cardiovascular Association (INCA), is being ... 24-25 April. , The meeting - considered by ... and allied health professionals - will show case the ...
    ... American Heart Association has partnered with Wiley-Blackwell to ... American Heart Association Clinical Series, designed to help ... patient care. , Each hardcover volume focuses ... on their areas of individual expertise under the ...
    ... YARDLEY, Pa., April 8 Core Essence Orthopaedics, ... tissue and skeletal repair of the extremities, today ... from the Food and Drug Administration (FDA) for ... in minimally invasive, arthroscopic surgery. SECURUS provides increased ...
    ... Educational Software (AES), a leading provider of software for ... to announce the addition of Susan DuRant to the ... is the parent of a child with autism and ... be a great asset to our company and help ...
    ... sales of OTC drugs grew by 2.4% from $17.8 ... to the latest research in Nonprescription Drugs USA ... and research firm Kline & Company.Private-label OTC medicines were ... antacids and allergy medicines posted the highest growth last ...
    ... A Florida judge has ruled that a state ... bona fide professional organizations is unconstitutional and violates the ... The American Academy of Implant Dentistry (AAID) said today ... qualifications and experience of dentists who perform implant procedures ...
    Cached Medicine News:Health News:Telemonitoring changes the working practice of cardiac nurses 2Health News:Telemonitoring changes the working practice of cardiac nurses 3Health News:Telemonitoring changes the working practice of cardiac nurses 4Health News:Telemonitoring changes the working practice of cardiac nurses 5Health News:Telemonitoring changes the working practice of cardiac nurses 6Health News:Wiley-Blackwell and the American Heart Association present new book series 2Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 2Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 3Health News:Autism Software Developer Announces Hiring of Susan DuRant as Director of Education 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 3Health News:AAID Hails Florida Court Verdict Allowing Advertising of Bona Fide Dental Credentials 2
    Sprint Quattro Secure™ is a Steroid-Eluting, True Bipolar, Active Fixation ICD Lead....
    TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
    The TVL-ADX lead is a thin, high-performing defibrillation lead that offers a true bipolar configuration designed for smarter sensing and low defibrillation threshold for greater patient safety margi...
    ... SPL defibrillator lead features a ... the flexibility and maneuverability of ... the physician who prefers a ... the SPL lead also promotes ...
    Medicine Products: